VanEck Biotech
CL$153,000
17
+CL$0+0% Friday 18:49
統計
當日最高
168,000
當日最低
168,000
52週最高
168,000
52週最低
136,730
成交量
1
平均成交量
0
市值
-
市盈率
-
股息收益率
0.43%
股息
665.46
即將到來
股息
0.43%股息收益率
10年增長
N/A
5年增長率
13.32%
3年增長率
24.37%
1年增長率
6.86%
人們還關注
此列表基於在 Stock Events 上關注 BBHCL.SN 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
iShares Biotechnology
IBB
市值7.41B
SPDR Biotech
XBI
市值7.19B
First Trust NYSE Arca Biotechnology Index Fund
FBT
市值1.12B
Virtus LifeSci Biotech Products
BBP
市值20.68M
Virtus LifeSci Biotech Clinical Trials
BBC
市值10.22M
Invesco Biotechnology & Genome
PBE
市值257.31M
Principal Healthcare Innovators
BTEC
市值16.4M
ALPS Medical Breakthroughs
SBIO
市值104.11M
Global X Genomics & Biotechnology
GNOM
市值95.21M
iShares Genomics Immunology and Healthcare
IDNA
市值135.25M
關於
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Show more...
首席執行官
國家
US
ISIN
US92189F7261